Published on 30 Jan 2025 on Investing.com
Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress...
Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress
NASDAQ.AMGN price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free